Literature DB >> 24339284

Application of array-based comparative genomic hybridization to pediatric neurologic diseases.

Jung Hye Byeon1, Eunsim Shin, Gun-Ha Kim, Kyungok Lee, Young Sook Hong, Joo Won Lee, Baik-Lin Eun.   

Abstract

PURPOSE: Array comparative genomic hybridization (array-CGH) is a technique used to analyze quantitative increase or decrease of chromosomes by competitive DNA hybridization of patients and controls. This study aimed to evaluate the benefits and yield of array-CGH in comparison with conventional karyotyping in pediatric neurology patients.
MATERIALS AND METHODS: We included 87 patients from the pediatric neurology clinic with at least one of the following features: developmental delay, mental retardation, dysmorphic face, or epilepsy. DNA extracted from patients and controls was hybridized on the Roche NimbleGen 135K oligonucleotide array and compared with G-band karyotyping. The results were analyzed with findings reported in recent publications and internet databases.
RESULTS: Chromosome imbalances, including 9 cases detected also by G-band karyotyping, were found in 28 patients (32.2%), and at least 19 of them seemed to be causally related to the abnormal phenotypes. Regarding each clinical symptom, 26.2% of 42 developmental delay patients, 44.4% of 18 mental retardation patients, 42.9% of 28 dysmorphic face patients, and 34.6% of 26 epilepsy patients showed abnormal array results.
CONCLUSION: Although there were relatively small number of tests in patients with pediatric neurologic disease, this study demonstrated that array-CGH is a very useful tool for clinical diagnosis of unknown genome abnormalities performed in pediatric neurology clinics.

Entities:  

Keywords:  Comparative genomic hybridization; child; nervous system disease

Mesh:

Year:  2014        PMID: 24339284      PMCID: PMC3874920          DOI: 10.3349/ymj.2014.55.1.30

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  33 in total

1.  Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation: a multicenter experience of 1499 clinical cases.

Authors:  Bixia Xiang; Hongbo Zhu; Yiping Shen; David T Miller; Kangmo Lu; Xiaofeng Hu; Hans C Andersson; Tarachandra M Narumanchi; Yueying Wang; Jose E Martinez; Bai-Lin Wu; Peining Li; Marilyn M Li; Tian-Jian Chen; Yao-Shan Fan
Journal:  J Mol Diagn       Date:  2010-01-21       Impact factor: 5.568

Review 2.  Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research.

Authors:  R Hochstenbach; J E Buizer-Voskamp; J A S Vorstman; R A Ophoff
Journal:  Cytogenet Genome Res       Date:  2011-11-02       Impact factor: 1.636

3.  The genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy due to mutations in ALDH7A1.

Authors:  Gunter Scharer; Chad Brocker; Vasilis Vasiliou; Geralyn Creadon-Swindell; Renata C Gallagher; Elaine Spector; Johan L K Van Hove
Journal:  J Inherit Metab Dis       Date:  2010-09-03       Impact factor: 4.982

4.  Homozygosity mapping in 64 Syrian consanguineous families with non-specific intellectual disability reveals 11 novel loci and high heterogeneity.

Authors:  R Abou Jamra; Sigrun Wohlfart; Markus Zweier; Steffen Uebe; Lutz Priebe; Arif Ekici; Susanne Giesebrecht; Ahmad Abboud; Mohammed Ayman Al Khateeb; Mahmoud Fakher; Saber Hamdan; Amina Ismael; Safia Muhammad; Markus M Nöthen; Johannes Schumacher; André Reis
Journal:  Eur J Hum Genet       Date:  2011-06-01       Impact factor: 4.246

5.  Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies.

Authors:  Carolien G F de Kovel; Holger Trucks; Ingo Helbig; Heather C Mefford; Carl Baker; Costin Leu; Christian Kluck; Hiltrud Muhle; Sarah von Spiczak; Philipp Ostertag; Tanja Obermeier; Ailing A Kleefuss-Lie; Kerstin Hallmann; Michael Steffens; Verena Gaus; Karl M Klein; Hajo M Hamer; Felix Rosenow; Eva H Brilstra; Dorothée Kasteleijn-Nolst Trenité; Marielle E M Swinkels; Yvonne G Weber; Iris Unterberger; Fritz Zimprich; Lydia Urak; Martha Feucht; Karoline Fuchs; Rikke S Møller; Helle Hjalgrim; Peter De Jonghe; Arvid Suls; Ina-Maria Rückert; Heinz-Erich Wichmann; Andre Franke; Stefan Schreiber; Peter Nürnberg; Christian E Elger; Holger Lerche; Ulrich Stephani; Bobby P C Koeleman; Dick Lindhout; Evan E Eichler; Thomas Sander
Journal:  Brain       Date:  2009-10-20       Impact factor: 13.501

6.  Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype.

Authors:  T Kleefstra; W A van Zelst-Stams; W M Nillesen; V Cormier-Daire; G Houge; N Foulds; M van Dooren; M H Willemsen; R Pfundt; A Turner; M Wilson; J McGaughran; A Rauch; M Zenker; M P Adam; M Innes; C Davies; A González-Meneses López; R Casalone; A Weber; L A Brueton; A Delicado Navarro; M Palomares Bralo; H Venselaar; S P A Stegmann; H G Yntema; H van Bokhoven; H G Brunner
Journal:  J Med Genet       Date:  2009-03-04       Impact factor: 6.318

7.  Elements of morphology: standard terminology for the head and face.

Authors:  Judith E Allanson; Christopher Cunniff; H Eugene Hoyme; Julie McGaughran; Max Muenke; Giovanni Neri
Journal:  Am J Med Genet A       Date:  2009-01       Impact factor: 2.802

8.  Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size.

Authors:  Marwan Shinawi; Pengfei Liu; Sung-Hae L Kang; Joseph Shen; John W Belmont; Daryl A Scott; Frank J Probst; William J Craigen; Brett H Graham; Amber Pursley; Gary Clark; Jennifer Lee; Monica Proud; Amber Stocco; Diana L Rodriguez; Beth A Kozel; Steven Sparagana; Elizabeth R Roeder; Susan G McGrew; Thaddeus W Kurczynski; Leslie J Allison; Stephen Amato; Sarah Savage; Ankita Patel; Pawel Stankiewicz; Arthur L Beaudet; Sau Wai Cheung; James R Lupski
Journal:  J Med Genet       Date:  2009-11-12       Impact factor: 6.318

Review 9.  1q44-qter trisomy: clinical report and review of the literature.

Authors:  Elisabetta Lenzini; Lucia Ballarati; Paola Drigo; Marco Carrozzi; Daniela Gambel-Benussi; Daniela Giardino; Vincenzo Petix; Melissa Rosa Rizzotto; Vanna Pecile
Journal:  Genet Test Mol Biomarkers       Date:  2009-02

10.  Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems.

Authors:  Trilochan Sahoo; Aaron Theisen; Jill A Rosenfeld; Allen N Lamb; J Britt Ravnan; Roger A Schultz; Beth S Torchia; Nicholas Neill; Ian Casci; Bassem A Bejjani; Lisa G Shaffer
Journal:  Genet Med       Date:  2011-10       Impact factor: 8.822

View more
  4 in total

1.  Comparative genomic hybridization and transcriptome sequencing reveal that two genes, OsI_14279 (LOC_Os03g62620) and OsI_10794 (LOC_Os03g14950) regulate the mutation in the γ-rl rice mutant.

Authors:  Xulong Wang; Fanhua Wang; Huiqiong Chen; Xiaoyu Liang; Yingmei Huang; Jicai Yi
Journal:  Physiol Mol Biol Plants       Date:  2017-08-22

2.  The clinical impact of chromosomal microarray on paediatric care in Hong Kong.

Authors:  Victoria Q Tao; Kelvin Y K Chan; Yoyo W Y Chu; Gary T K Mok; Tiong Y Tan; Wanling Yang; So Lun Lee; Wing Fai Tang; Winnie W Y Tso; Elizabeth T Lau; Anita S Y Kan; Mary H Tang; Yu-Lung Lau; Brian H Y Chung
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

3.  Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability.

Authors:  Jin Sook Lee; Hee Hwang; Soo Yeon Kim; Ki Joong Kim; Jin Sun Choi; Mi Jung Woo; Young Min Choi; Jong Kwan Jun; Byung Chan Lim; Jong Hee Chae
Journal:  Ann Lab Med       Date:  2018-09       Impact factor: 3.464

4.  Phenotypic Analysis of Korean Patients with Abnormal Chromosomal Microarray in Patients with Unexplained Developmental Delay/Intellectual Disability.

Authors:  Hyo Jeong Kim; Chang Il Park; Jae Woo Lim; Gyung Min Lee; Eunhae Cho; Hyon J Kim
Journal:  Yonsei Med J       Date:  2018-05       Impact factor: 2.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.